IASO Biotherapeutics raised $108M Series C venture round, led by Wei Ying.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
CDH InvestmentsLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$241.9M
Top Valuation
-
IASO Biotherapeutics raised $108M in a Series C round.
The round was announced on 09/16/21.
The round was led by Wei Ying.